Effectiveness of Financial Incentives and Text Messages to Improve Health Care in Population With Moderate and High Cardiovascular Risk
Effectiveness of Financial Incentives and Text Messages to Improve Health Care of Vulnerable Population With Moderate and High Cardiovascular Risk in Argentina: A Randomized Cluster Trial
Cardiovascular diseases are increasing throughout the developing world and are the cause of almost 16.7 million deaths each year, of which 80% occur in low and middle-income countries. As more than three fourth of the global burden of cardiometabolic diseases are related to risk factors connected with lifestyles or behaviors, such as smoking, unhealthy eating, low physical activity, and harmful consumption of alcohol. This burden could be dramatically reduced by changing individual behaviors. This study is focused on interventions that are aimed to improve the adherence to treatment in cardiovascular disease (hypertension), based on a Behavioral Economics approach. Most of public policies targeted to tackle NCDs utilize a rational economic model of behavior. Behavioral economics, by using insights from cognitive psychology and other social sciences, has drawn a lot of attention for its potential to increase healthy behaviors. Interventions informed by BE principles seek to rearrange the social or physical environment in such a way to 'nudge' people towards healthier choices and behaviors.
Main objective: to assess whether the implementation of two strategies based on behavioral economics, that include the use of a financial incentive scheme and specific framing to beneficiaries (i.e. mobile health interventions), increase the referral, evaluation and follow-up of people with moderate and high cardiovascular risk in the public health network, compared to the usual strategy.
Design: A cluster-randomized pragmatic clinical trial will be performed. The randomization unit will be the Community Health Centers (CHC) and the intervention groups (2 arms) or control will be assigned to 9 health centers in total (3 CHC per arm).
Population: This RCT is going to be conducted in selected CHC of Salta. Nine CHC will be selected, which will be randomized: 3 centers to the control, 3 centers to framing intervention with messages and 3 centers to the intervention with incentives.
A total of 900 patients ≥ 40 years, without health coverage and with a 10-year cardiovascular risk ≥ 10% will participate in this study.
Follow up: 3 month
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Salta
-
Guemes, Salta, Argentine, 4400
- 1º DE MAYO
-
Guemes, Salta, Argentine, 4400
- Barrio Cooperativa
-
Guemes, Salta, Argentine, 4400
- Barrio La Tablada
-
Guemes, Salta, Argentine, 4400
- Campo Santo
-
Guemes, Salta, Argentine, 4400
- CIC
-
Guemes, Salta, Argentine, 4400
- EL BORDO
-
Guemes, Salta, Argentine, 4400
- El cruce
-
Guemes, Salta, Argentine, 4400
- Villa Tranquila
-
Güemes, Salta, Argentine, 4400
- Los Olivos
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Subjects that only have public health coverage.
- Residence in the area of influence of the health centers of the study.
- Have a mobile phone for personal use.
- 10 year cardiovascular risk ≥ 10%
Exclusion Criteria:
- Pregnant women.
- Immobilized people.
- Persons who do not give their informed consent.
- People planning to move in the next 3 months
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Soins habituels
|
|
|
Expérimental: Financial incentives
|
The study nurses will schedule an appointment with the doctor at the health center, within 4 weeks from the participant's inclusion in the study.
Participants who attend the first visit at the health center will receive a direct incentive consisting of the payment of a limited amount to be determined (approximately AR $ 150-200) through a shopping voucher for the amount mentioned.
Participants attending the follow-up visit at the health center within 3 months from their inclusion in the study will participate in a lottery.
The lottery will offer the possibility of winning a new voucher with a probability of 1 in 3. Participants who do not attend the health center will not receive any incentive.
|
|
Expérimental: Framing (SMS)
|
After inclusion, participants will receive weekly text messages (SMS) using a specific framing or formulation of the message, highlighting the potential benefits and positive aspects of health care.
These messages will promote follow-up visits, adherence to treatment, and benefits to be gained from a follow-up visit with the physician.
Messages will be sent with a frequency of two per week during the first 30 days and then 1 per week until the end of the follow-up.
These messages will have no cost to participants.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Attendance at the first medical visit
Délai: 4 weeks
|
Proportion of patients who attended and completed the first clinical visit to the health center
|
4 weeks
|
|
Attendance at the second medical visit
Délai: 8 weeks after first medical visit
|
Proportion of patients who attended and completed the second clinical visit to the health center
|
8 weeks after first medical visit
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Attendance at least one clinical visit
Délai: 12 weeks
|
Proportion of patients who attended and completed at least one clinical visit to the health
|
12 weeks
|
Collaborateurs et enquêteurs
Collaborateurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- AR-T1087-P0001/2
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Financial incentives
-
University Hospital, LillePas encore de recrutement